In muscle, phosphorylase b is kept in an inactivated state by:
Acetyl CoA can be directly converted to all except:
Acetyl CoA, which coordinates carbohydrate, ketone, and fat pathways, can be directly converted to all of the following, except:
Which of the following pathways is activated by insulin?
All of the following metabolic changes occur during prolonged fasting when compared with fasting for 12-24 hours, except:
What is the primary fuel source for neurons during starvation?
Which of the following changes are typically seen on the 5th day of fasting?
Which metabolic process is common in humans and bacteria?
All of the following metabolic pathways occur in both the cytoplasm and mitochondria, except:
Which of the following metabolic pathways does not occur in mitochondria?
Explanation: **Explanation:** Glycogen phosphorylase is the rate-limiting enzyme of glycogenolysis. It exists in two forms: **Phosphorylase a** (phosphorylated/active) and **Phosphorylase b** (dephosphorylated/inactive). **Why cAMP is the correct answer:** In the context of this specific question, **cAMP** acts as the secondary messenger that triggers the activation of Protein Kinase A (PKA). PKA then phosphorylates Phosphorylase Kinase, which in turn converts the inactive **Phosphorylase b** into the active **Phosphorylase a**. Therefore, the presence of cAMP is the signal to transition *away* from the inactivated state. (Note: In some exam contexts, this question is framed to highlight that in the *absence* of such hormonal signals, the enzyme remains in its default 'b' state). **Analysis of Options:** * **ATP (Option B):** ATP is an allosteric **inhibitor** of phosphorylase b. High energy levels signal the cell that glycogen breakdown is unnecessary. * **Calcium (Option C):** Calcium is a potent **activator**. During muscle contraction, $Ca^{2+}$ binds to the calmodulin subunit of phosphorylase kinase, activating it even without cAMP, thus converting 'b' to 'a'. * **Glucose (Option D):** Glucose is an allosteric inhibitor primarily in the **liver**, not the muscle. It shifts the equilibrium of phosphorylase a to the T-state (inactive). **High-Yield Clinical Pearls for NEET-PG:** 1. **McArdle Disease (GSD Type V):** Caused by a deficiency of skeletal muscle glycogen phosphorylase. Patients present with exercise intolerance, muscle cramps, and myoglobinuria. 2. **Dual Control in Muscle:** Muscle phosphorylase is regulated **hormonally** (via Epinephrine/cAMP) and **allosterically** (via AMP and $Ca^{2+}$). 3. **AMP vs. ATP:** In muscle, **AMP** is a unique allosteric activator of phosphorylase b that works without phosphorylation, signaling low energy status.
Explanation: **Explanation:** The conversion of Acetyl CoA to glucose is impossible in humans because the **Pyruvate Dehydrogenase (PDH) complex reaction is irreversible**. This reaction converts Pyruvate to Acetyl CoA, but there is no human enzyme capable of reversing this step. 1. **Why Glucose is the Correct Answer:** For a substance to be gluconeogenic, it must be convertible to Pyruvate or Oxaloacetate (OAA). While Acetyl CoA enters the TCA cycle by condensing with OAA to form Citrate, two carbons are lost as $CO_2$ during the cycle. Consequently, there is **no net gain of carbon** to form a new molecule of OAA for gluconeogenesis. Thus, Acetyl CoA cannot be used to synthesize glucose. 2. **Analysis of Incorrect Options:** * **Fatty Acids:** Acetyl CoA is the primary building block for lipogenesis. It is converted to Malonyl CoA by Acetyl CoA Carboxylase (the rate-limiting step) to initiate fatty acid synthesis. * **Cholesterol:** All 27 carbon atoms of cholesterol are derived from Acetyl CoA via the HMG-CoA reductase pathway (Mevalonate pathway). * **Ketone Bodies:** In the liver, during fasting or starvation, Acetyl CoA is diverted to form Acetoacetate, $\beta$-hydroxybutyrate, and Acetone (Ketogenesis). **NEET-PG High-Yield Pearls:** * **The "PDH Dead-end":** Remember that while plants and some bacteria can convert Acetyl CoA to glucose via the **Glyoxylate Cycle**, humans lack the enzymes Isocitrate lyase and Malate synthase. * **Odd-chain Fatty Acids:** Unlike even-chain fatty acids, odd-chain fatty acids produce **Propionyl CoA**, which *can* be converted to Succinyl CoA and enter gluconeogenesis. * **Ketogenic Amino Acids:** Leucine and Lysine are purely ketogenic because they are metabolized directly to Acetyl CoA.
Explanation: **Explanation:** The correct answer is **A. Glucose**. This is a fundamental concept in biochemistry: **Acetyl CoA cannot be converted into glucose in humans.** **1. Why Glucose is the Correct Answer (The "Irreversibility" Concept):** The conversion of Pyruvate to Acetyl CoA is catalyzed by the **Pyruvate Dehydrogenase (PDH) complex**. This reaction is **oxidative decarboxylation** and is physiologically **irreversible**. Once Acetyl CoA is formed, it cannot be converted back to pyruvate or oxaloacetate (via a net gain) to enter the gluconeogenic pathway. While Acetyl CoA enters the TCA cycle by condensing with oxaloacetate, two carbons are lost as $CO_2$ during the cycle, resulting in **no net synthesis of glucose** from Acetyl CoA. **2. Why the other options are incorrect:** * **B. Fatty acids:** Acetyl CoA is the primary building block for lipogenesis. In the cytosol, it is converted to Malonyl CoA by Acetyl CoA Carboxylase (the rate-limiting step) to synthesize long-chain fatty acids. * **C. Cholesterol:** All 27 carbon atoms of cholesterol are derived from Acetyl CoA. The pathway involves the formation of HMG-CoA, which is then reduced to Mevalonate. * **D. Ketone bodies:** During fasting or starvation, excess Acetyl CoA produced from $\beta$-oxidation is diverted to **Ketogenesis** in the liver mitochondria to form acetoacetate and $\beta$-hydroxybutyrate. **NEET-PG High-Yield Pearls:** * **The PDH Complex** is the "bridge" between glycolysis and the TCA cycle. * **Odd-chain fatty acids** are the only lipids that can be glucogenic because their terminal 3-carbon unit, **Propionyl CoA**, can be converted to Succinyl CoA (a TCA intermediate). * **Leucine and Lysine** are purely ketogenic amino acids because they are degraded directly to Acetyl CoA or Acetoacetate.
Explanation: **Explanation:** Insulin is an **anabolic hormone** secreted by the pancreatic beta cells in the fed state. Its primary goal is to lower blood glucose levels by promoting glucose utilization and storage while inhibiting glucose production. **Why Glycolysis is Correct:** Insulin activates **Glycolysis** (the breakdown of glucose for energy) by inducing key regulatory enzymes: **Glucokinase, Phosphofructokinase-1 (PFK-1), and Pyruvate Kinase**. It specifically stimulates the synthesis of Fructose-2,6-bisphosphate, which is the most potent allosteric activator of PFK-1, the rate-limiting step of glycolysis. **Why Other Options are Incorrect:** * **Ketone body synthesis & Beta-oxidation:** These are **catabolic pathways** activated by Glucagon and Epinephrine during fasting or starvation. Insulin inhibits Hormone Sensitive Lipase (HSL), thereby reducing the fatty acid supply required for beta-oxidation and subsequent ketogenesis. * **Gluconeogenesis:** This is the synthesis of glucose from non-carbohydrate sources. Insulin suppresses this pathway by inhibiting key enzymes like **PEPCK** and **Fructose-1,6-bisphosphatase** to prevent further increases in blood glucose. **High-Yield Clinical Pearls for NEET-PG:** * **The "Dephosphorylation" Rule:** Insulin generally acts by activating **protein phosphatases**, keeping key metabolic enzymes in their **dephosphorylated state**. For most rate-limiting enzymes (except Glycogen Synthase), the dephosphorylated form is the **active** form. * **GLUT-4:** Insulin increases glucose uptake specifically in **skeletal muscle and adipose tissue** by mobilizing GLUT-4 transporters to the cell membrane. * **Lipogenesis:** Insulin is the primary stimulator of fatty acid synthesis (via activation of Acetyl-CoA Carboxylase).
Explanation: **Explanation:** The metabolic transition from **early fasting (12–24 hours)** to **prolonged fasting (starvation)** is defined by a shift from glucose dependency to protein conservation and ketone utilization. **Why Option B is the Correct Answer:** In early fasting (12–24 hours), liver gluconeogenesis peaks to maintain blood glucose levels as glycogen stores are depleted. However, in **prolonged fasting**, liver gluconeogenesis actually **decreases**. This is a protective mechanism to prevent the total depletion of muscle mass (the primary source of glucogenic amino acids like alanine). Instead, the kidney becomes a significant contributor to gluconeogenesis, and the body shifts its primary fuel source to fatty acids and ketone bodies. **Analysis of Incorrect Options:** * **Option A & D:** During prolonged fasting, the brain undergoes a metabolic adaptation. It begins to utilize **ketone bodies** (3-hydroxybutyrate and acetoacetate) for up to 70% of its energy needs. Consequently, the **brain's glucose requirement decreases** significantly, further sparing muscle protein. * **Option C:** In the first few days of fasting, muscle protein breakdown is high to provide substrates for gluconeogenesis. In prolonged fasting, this **degradation decreases** as the body prioritizes protein conservation for survival, switching the metabolic "burden" to adipose tissue (lipolysis). **High-Yield NEET-PG Pearls:** * **Primary fuel in starvation:** Fatty acids (for most tissues) and Ketone bodies (for the brain). * **Protein Sparing Effect:** This is the hallmark of prolonged fasting, achieved by the brain's switch to ketones. * **Organ Shift:** In late starvation, the **kidney** can contribute up to 40-50% of the total gluconeogenic output. * **Key Enzyme:** Hormone-sensitive lipase (HSL) is highly active in starvation to drive lipolysis.
Explanation: **Explanation:** The brain is a metabolically demanding organ that primarily relies on **glucose** under normal physiological conditions. However, during prolonged starvation (typically after 3–4 days), the body undergoes metabolic adaptation to preserve muscle mass and maintain brain function. **1. Why Ketone Bodies are Correct:** During starvation, the liver undergoes extensive fatty acid oxidation, leading to the production of **ketone bodies** (Acetoacetate and β-hydroxybutyrate). Unlike long-chain fatty acids, ketone bodies are water-soluble and can cross the **blood-brain barrier (BBB)**. Once in the neurons, they are converted back into Acetyl-CoA to enter the TCA cycle, providing up to 60–70% of the brain's energy requirements. This "glucose-sparing effect" is crucial for survival. **2. Why Other Options are Incorrect:** * **Glucose:** While it is the *obligatory* fuel in the fed state, its availability is limited during starvation. The brain shifts away from glucose to prevent excessive muscle proteolysis (the source of gluconeogenic precursors). * **Fatty Acids:** Although they are the primary fuel for the rest of the body during starvation, they **cannot cross the BBB** in significant amounts and thus cannot be used by neurons. * **Amino Acids:** These are used for gluconeogenesis in the liver/kidney rather than being a direct primary fuel source for neurons. **High-Yield NEET-PG Pearls:** * **Enzyme Note:** The brain can use ketones because it possesses the enzyme **Thiophorase** (Succinyl-CoA:3-ketoacid CoA transferase). The liver lacks this enzyme, preventing it from consuming the ketones it produces. * **The "Rule of 3":** Glucose is the main fuel for <3 days of starvation; Ketone bodies become the primary fuel after >3 days. * **Red Blood Cells (RBCs):** Unlike the brain, RBCs *always* require glucose (anaerobic glycolysis) because they lack mitochondria and cannot oxidize ketones.
Explanation: In the metabolic transition from early fasting to prolonged starvation (typically after 3–5 days), the body undergoes significant hormonal and substrate shifts to preserve protein and prioritize brain fuel. ### **Why "Decreased Growth Hormone" is Correct** Growth Hormone (GH) typically peaks during the **early phase of fasting** (first 24–72 hours) to stimulate lipolysis and antagonize insulin, helping maintain blood glucose. However, as fasting extends into the **5th day and beyond**, GH levels paradoxically **decrease**. This is a protective adaptation to reduce protein catabolism and lower the basal metabolic rate, as the body shifts its primary energy reliance toward ketone bodies. ### **Analysis of Incorrect Options** * **A. Increase in FFA levels:** Free Fatty Acid (FFA) levels rise sharply in the first 48 hours. By the 5th day, they generally plateau or slightly decline as the liver converts them into ketone bodies (acetoacetate and β-hydroxybutyrate), which become the dominant circulating fuel. * **B. Decreased glucose tolerance:** While "starvation diabetes" (reduced insulin sensitivity) occurs during fasting, it is a characteristic of the **early** phase. By day 5, the metabolic focus is no longer on glucose regulation but on ketosis. * **C. Decreased level of Insulin:** Insulin levels drop significantly within the **first 12–24 hours** of fasting. By the 5th day, insulin is already at a basal nadir; it does not "typically" show a new or characteristic change specific to day 5 compared to day 2. ### **NEET-PG High-Yield Pearls** * **Brain Fuel Shift:** After 3 days of starvation, the brain derives ~30% of its energy from ketones; by 3 weeks, this rises to 70%. * **Gluconeogenesis:** The primary source of glucose after 48 hours is **renal gluconeogenesis** (contributing up to 40%), whereas hepatic gluconeogenesis dominates early fasting. * **Protein Sparing:** The hallmark of prolonged starvation (Day 5+) is a **decrease in urinary nitrogen excretion**, reflecting the body's effort to spare muscle mass.
Explanation: **Explanation:** **1. Why Purine Synthesis is Correct:** Purine synthesis (forming Adenine and Guanine) is a fundamental metabolic process essential for the creation of DNA and RNA. Because all living organisms, including humans and bacteria, must replicate their genetic material and synthesize proteins, the biochemical pathways for purine synthesis are highly conserved across evolution. Both humans and bacteria utilize the **De Novo pathway** (starting from PRPP, glutamine, and glycine) and **Salvage pathways** to maintain their nucleotide pools. This shared pathway is clinically significant; for example, **Sulfonamides** act as antibiotics by inhibiting bacterial folic acid synthesis, which is a necessary cofactor for purine production. **2. Why Other Options are Incorrect:** * **B. Nitrogen Fixation:** This is the conversion of atmospheric $N_2$ into ammonia. This process is exclusive to certain prokaryotes (e.g., *Rhizobium*, *Azotobacter*) containing the enzyme **nitrogenase**. Humans cannot fix nitrogen and must obtain it through dietary protein. * **C. Mucolipid Formation:** Mucolipids are complex lipids primarily associated with animal cell lysosomes. While bacteria have complex cell walls (peptidoglycans/LPS), they do not form the specific mucolipids found in human metabolic storage disorders (Mucolipidosis). * **D. Nonoxidative Photophosphorylation:** This is a component of photosynthesis used by plants and photosynthetic bacteria (like Cyanobacteria) to generate ATP using light energy. Humans are heterotrophs and rely on oxidative phosphorylation in the mitochondria. **High-Yield Clinical Pearls for NEET-PG:** * **Rate-limiting enzyme of Purine Synthesis:** Glutamine-PRPP amidotransferase. * **Key Amino Acids required:** Glycine (contributes C4, C5, N7), Aspartate, and Glutamine. * **Drug Link:** **Methotrexate** inhibits dihydrofolate reductase in both humans (cancer) and bacteria (though Trimethoprim is more specific for bacterial DHFR), effectively halting purine synthesis.
Explanation: **Explanation:** The correct answer is **Glycolysis** because it is a purely **cytosolic** pathway. All ten enzymatic steps of glycolysis, from glucose to pyruvate, occur within the cytoplasm of the cell. **Why the other options are incorrect:** * **Gluconeogenesis:** This pathway is compartmentalized. It begins in the **mitochondria** (pyruvate to oxaloacetate via pyruvate carboxylase) and continues in the **cytoplasm** (oxaloacetate is malate-shuttled out to become PEP). The final step (G6P to Glucose) occurs in the **endoplasmic reticulum**. * **Heme Synthesis:** This pathway "sandwiches" between compartments. The **first step** (ALA synthase) and the **last three steps** occur in the **mitochondria**, while the intermediate steps occur in the **cytoplasm**. * **Urea Cycle:** This cycle is split. The **first two steps** (Carbamoyl phosphate synthetase I and Ornithine transcarbamoylase) occur in the **mitochondrial matrix**, while the remaining enzymes are located in the **cytoplasm**. **High-Yield NEET-PG Pearls:** * **Purely Cytosolic Pathways:** Glycolysis, HMP Shunt, Fatty Acid Synthesis, Cholesterol Synthesis, and Translation. * **Purely Mitochondrial Pathways:** TCA Cycle (Krebs), Electron Transport Chain (ETC), Beta-oxidation of fatty acids, and Ketogenesis. * **Dual Compartment Pathways (Mnemonic: "HUG"):** **H**eme synthesis, **U**rea cycle, and **G**luconeogenesis. * **Key Enzyme Location:** Pyruvate Carboxylase (Gluconeogenesis) is a key mitochondrial marker, while Lactate Dehydrogenase (Glycolysis) is a cytosolic marker.
Explanation: ### Explanation The correct answer is **Fatty acid synthesis (Option C)**. **1. Why Fatty Acid Synthesis is the Correct Answer:** De novo fatty acid synthesis (Lipogenesis) occurs primarily in the **cytosol** of the cell. The process requires NADPH (provided by the HMP shunt) and Acetyl-CoA. Since Acetyl-CoA is produced in the mitochondria but cannot cross the mitochondrial membrane, it is transported to the cytosol in the form of **Citrate** (the "Citrate Shuttle"). Once in the cytosol, the Fatty Acid Synthase (FAS) multienzyme complex carries out the synthesis. **2. Why the Other Options are Incorrect:** * **Beta-oxidation (A):** This is the breakdown of fatty acids to generate energy, which occurs exclusively within the **mitochondrial matrix**. Fatty acids are transported into the mitochondria via the **Carnitine shuttle**. * **Urea Cycle (B):** This is a **dual-compartment** pathway. The first two steps (Carbamoyl phosphate synthetase I and Ornithine transcarbamoylase) occur in the **mitochondria**, while the remaining steps occur in the cytosol. * **Heme Synthesis (D):** This is also a **dual-compartment** pathway. The first step (ALA synthase) and the final three steps occur in the **mitochondria**, while the intermediate steps occur in the cytosol. **3. NEET-PG High-Yield Clinical Pearls:** * **Mnemonic for Mitochondrial Pathways:** "The **K**etone **B**odies **U**sually **H**ave **M**any **O**xidations" (**K**rebs cycle, **B**eta-oxidation, **U**rea cycle (partial), **H**eme synthesis (partial), **M**itochondria, **O**xidative phosphorylation). * **Purely Cytosolic Pathways:** Glycolysis, HMP Shunt, Fatty acid synthesis, and Cholesterol synthesis. * **Dual-Compartment Pathways (Mnemonic: HUG):** **H**eme synthesis, **U**rea cycle, and **G**luconeogenesis.
Fed State Metabolism
Practice Questions
Fasting State Metabolism
Practice Questions
Starvation Adaptation
Practice Questions
Metabolic Adaptations During Exercise
Practice Questions
Interorgan Metabolite Exchange
Practice Questions
Metabolic Regulation: Hormonal Control
Practice Questions
Metabolic Regulation: Substrate Availability
Practice Questions
Metabolic Syndrome
Practice Questions
Obesity: Biochemical Aspects
Practice Questions
Liver as Metabolic Hub
Practice Questions
Muscle Metabolism
Practice Questions
Brain Metabolism and Ketone Bodies
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free